|
||||||||
September 2001 with updates added December 2003 Download PDF Booklet Version (PDF 1.8MB/ September 2001, updates added 12/03) Questions and Answers |
|||||||||||||||||||||||||||||||||||||
As of September 2001, annual influenza epidemics cause infection in 10-20 % of the population and result in an average of >110,000 hospitalizations and 20,000 deaths in the United States. Persons most susceptible to complications or death from influenza are:
Update (December 2003): For updated incidence and mortality data click here. 2. What are the symptoms of influenza infection? Influenza
is a respiratory illness characterized by the abrupt onset of fever, chills,
headache, myalgias, i.e. body aches with accompanying fatigue cough, sore
throat, and nasal congestion. While the fever, body aches, and headache
may typically last for three to five days, the cough and fatigue may last
for more than two weeks. Some persons may not have typical influenza symptoms,
but exhibit exacerbation of chronic
medical conditions. Some children primarily may have fever, with nausea,
vomiting or abdominal pain, and infants may have symptoms similar to a
severe systemic bacterial infection. 3. What are the complications from influenza infection? The most
common complications are secondary bacterial pneumonia and worsening of
chronic
medical conditions. Influenza virus also can cause primary pneumonia
, but is much less common. Rarely, children taking aspirin can develop
Reye's syndrome if they get sick with influenza. 4. How is influenza transmitted? Influenza
is easily transmitted from person-to-person. The virus is spread primarily
by the coughing and sneezing of infected persons or sometimes, by direct
contact, either with infected persons or a contaminated surface. Once
influenza is introduced into a facility by infected healthcare personnel,
patients, or visitors, it can quickly spread and cause illness in other
hospitalized patients and healthcare personnel, especially in those who
are unvaccinated. During an outbreak in a hospital ward or nursing home,
as many as 70% of staff and patients may become infected. 5. What is the incubation period for influenza and how long is a person contagious? Infected
persons start to develop symptoms 1-4 days after they are exposed. They
may be able to spread influenza to other people from the day before getting
symptoms through 5-7 days after symptoms start. Children may be contagious
for 7 or more days. 6. How can influenza outbreaks in health care facilities be prevented? The
most important means to prevent influenza illness from spreading in a
health care facility is influenza vaccination of both patients and healthcare
personnel. The
Advisory Committee on Immunization Practices recommends annual vaccination
of all healthcare personnel. However, in part due to low vaccination rates,
less than 100% efficacy, and because influenza-infected patients will
be admitted from the community, outbreaks of influenza can occur. When
influenza is introduced into a health care facility, prompt recognition
of influenza infection and initiation of infection control measures can
limit the spread of disease. 7. Why should acute care facilities conduct surveillance for influenza and influenza-like illness? An active
surveillance program for influenza and influenza-like
illness can help acute care facilities identify outbreaks of influenza
early in their course and prevent influenza from spreading to patients
and healthcare personnel, thereby decreasing influenza-related complications
among patients and reducing work absenteeism. When the onset of influenza
season in the community is identified, facility leaders should initiate
measures to increase awareness and intensify efforts to diagnose and prevent
influenza illness in both patients and healthcare personnel. 8. How should surveillance be conducted? Surveillance
can be conducted in a number of settings including:
2) Emergency Department surveillance
4) Laboratory surveillance
9. When should surveillance be conducted? Acute care
facilities should conduct surveillance for acute care facility-acquired
influenza or influenza-like
illness, particularly during the influenza season (from October through
April in North America). However, sporadic cases of influenza can occur
at any time of the year. 10. Why is laboratory testing for influenza important? Influenza
is very difficult to differentiate from other pathogens on the basis of
clinical symptoms alone. Other pathogens that can cause similar symptoms
include, but are not limited to, Mycoplasma pneumoniae, adenovirus,
respiratory syncytial virus, rhinovirus, parainfluenza viruses, and Legionella
spp. Many pathogens, including influenza, RSV, and parainfluenza,
cause outbreaks in a seasonal pattern. 11. When should influenza testing be done? Based on
facility surveillance, infection control personnel should develop threshold
levels of influenza or influenza-like
illness at which influenza testing and outbreak control measures should
be initiated. Physicians may have a lower threshold for testing individuals
at high risk for influenza-related complications. Droplet precautions
should be initiated pending laboratory confirmation of influenza. 12. What laboratory tests can be used to confirm the diagnosis of influenza? Update (December 2003): For new flu tests click here Appropriate patient samples to collect for laboratory testing can include a nasopharyngeal or throat swab, from adults or nasal wash, or nasal aspirates, depending on which rapid test is used. Samples should be collected within the first 4 days of illness. Rapid influenza tests provide results within 24 hours; viral culture provides results in 3-10 days. Most of the rapid tests are approximately >70% sensitive for detecting influenza and >90% specific. Because as many as 30% of samples that would be positive for influenza by viral culture may give a negative rapid test result, negative rapid tests should be followed by viral culture in a sub-sample of the swabs collected. Viral culture can also identify other causes of influenza-like illness when influenza is not the cause. Serum samples can be tested for influenza antibody to diagnose acute infections. Two samples should be collected per person: one sample within the first week of illness and a second sample 2-4 weeks later. If antibody levels increase from the first to the second sample, influenza infection likely occurred. Because of the length of time needed for a diagnosis of influenza by serologic testing, other diagnostic testing should be used for rapid detection of possible outbreaks. Update
(December 2003): For updated table on influenza laboratory diagnostic
procedures click
here 13. What control measures should be used for influenza or influenza-like illness? a) Cohort those with influenza or influenza-like illness together on a ward designated to accept patients with suspected or confirmed influenza. b) Initiate droplet precautions for persons with influenza-like illness or confirmed influenza infection, including wearing masks when within 3 feet of the patient, wearing gowns if clothing is likely to be soiled by body fluids, and practicing hand hygiene before and after patient contact. c) Offer influenza vaccine to patients and healthcare personnel who have not been vaccinated. d) Consider offering influenza antiviral medications for treatment of ill patients and healthcare personnel and for prophylaxis of exposed patients, unvaccinated personnel, and those vaccinated <2 weeks before exposure. Update (December 2003): For updated clinical information click here e) Monitor personnel for influenza-like illness and restrict ill personnel from patient care. f) Restrict visitors with influenza-like illness. g) Continue
to monitor for healthcare facility-acquired influenza and for patients
being admitted to the facility who have influenza infection.
14. What can acute care facilities do to prepare for possible influenza outbreaks? a) Make sure that all personnel receive influenza vaccination by:
b) Offer vaccine to unvaccinated patients before they are discharged. c) Have a written policy concerning influenza outbreak management and ensure that key healthcare personnel, especially nurses, are aware of it. d) Disseminate information to physicians about influenza testing and use of influenza antiviral medication. e) Institute
surveillance for influenza-like
illness among healthcare personnel and patients. Update
(December 2003): For updated table on influenza laboratory diagnostic
procedures click
here
|
This page
last reviewed December 31, 2003
|